Nuvectis Pharma, Inc. (NVCT) Tops Q1 EPS by 53c

Nuvectis Pharma, Inc. (NASDAQ: NVCT) reported Q1 EPS of $0.27, $0.53 better than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Nuvectis Pharma, Inc. (NVCT) click here.

You May Also Be Interested In

• Pizza Hut CEO Aaron Powell resigns
• GitLab Inc (GTLB) Tops Q2 EPS by 7c, Beats on Revenue
• Honda Aims To Cut 1.5 Trillion Yen ($9.4 Billion) In Costs By 2030, According To A Source And Internal Documents - Reuters